Regeneron hosted a celebration to recognize the achievements of the 17 students selected as the Westchester 2025 Regeneron Science Talent Search Scholars. Beginning in 1942, the contest […] ...
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
1d
Hosted on MSNNew science research fair set for middle schoolers from Westchester, Rockland, PutnamA new in-person science and engineering research fair for middle school students from Westchester, Rockland and Putnam counties will premier on Saturday, April 26 at Edgemont High School. The ...
Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...
Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...
Regeneron Pharmaceuticals Inc.'s stock rose 3% early Tuesday, after the company posted better-than-expected fourth-quarter earnings, boosted by strong demand for a new formulation of its blockbuster ...
Addison Shea is one of 40 finalists for the Science Talent Search finals in Washington, D.C., in March. Addison Shea couldn’t ...
Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...
A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...
Investment analysts at Leerink Partnrs increased their Q4 2024 earnings estimates for shares of Regeneron Pharmaceuticals in a research report issued on Tuesday, January 28th. Leerink Partnrs analyst ...
Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from ...
Join Lee Rennick from the CIO100 with Bob McCowan, SVP & CIO, Regeneron as he discusses the award-winning Centralized Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results